147 related articles for article (PubMed ID: 38375764)
21. Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
Gershenwald JE; Scolyer RA; Hess KR; Sondak VK; Long GV; Ross MI; Lazar AJ; Faries MB; Kirkwood JM; McArthur GA; Haydu LE; Eggermont AMM; Flaherty KT; Balch CM; Thompson JF;
CA Cancer J Clin; 2017 Nov; 67(6):472-492. PubMed ID: 29028110
[TBL] [Abstract][Full Text] [Related]
22. The utility of PET-CT in the staging and management of advanced and recurrent malignant melanoma.
Twycross SH; Burger H; Holness J
S Afr J Surg; 2019 Sep; 57(3):44-49. PubMed ID: 31392864
[TBL] [Abstract][Full Text] [Related]
23. Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma.
Blaheta HJ; Ellwanger U; Schittek B; Sotlar K; MacZey E; Breuninger H; Thelen MH; Bueltmann B; Rassner G; Garbe C
J Invest Dermatol; 2000 Apr; 114(4):637-42. PubMed ID: 10733666
[TBL] [Abstract][Full Text] [Related]
24. International Validation of the American Joint Committee on Cancer's 7th Edition Classification of Uveal Melanoma.
AJCC Ophthalmic Oncology Task Force
JAMA Ophthalmol; 2015 Apr; 133(4):376-83. PubMed ID: 25555246
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of extensive initial staging procedure in intermediate/high-risk melanoma patients.
Vereecken P; Laporte M; Petein M; Steels E; Heenen M
J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):66-73. PubMed ID: 15649194
[TBL] [Abstract][Full Text] [Related]
26. Predicting survival outcome of localized melanoma: an electronic prediction tool based on the AJCC Melanoma Database.
Soong SJ; Ding S; Coit D; Balch CM; Gershenwald JE; Thompson JF; Gimotty P;
Ann Surg Oncol; 2010 Aug; 17(8):2006-14. PubMed ID: 20379784
[TBL] [Abstract][Full Text] [Related]
27. Optimal surveillance strategies for patients with stage 1 cutaneous melanoma post primary tumour excision: three systematic reviews and an economic model.
Vale L; Kunonga P; Coughlan D; Kontogiannis V; Astin M; Beyer F; Richmond C; Wilson D; Bajwa D; Javanbakht M; Bryant A; Akor W; Craig D; Lovat P; Labus M; Nasr B; Cunliffe T; Hinde H; Shawgi M; Saleh D; Royle P; Steward P; Lucas R; Ellis R
Health Technol Assess; 2021 Nov; 25(64):1-178. PubMed ID: 34792018
[TBL] [Abstract][Full Text] [Related]
28. External validation of the American Joint Committee on Cancer 8th edition melanoma staging system: who needs adjuvant treatment?
Madu MF; Franke V; Van de Wiel BA; Klop WMC; Jóźwiak K; van Houdt WJ; Wouters MWJM; van Akkooi ACJ
Melanoma Res; 2020 Apr; 30(2):185-192. PubMed ID: 31651715
[TBL] [Abstract][Full Text] [Related]
29. Classification and staging of melanoma.
Gershenwald JE; Buzaid AC; Ross MI
Clin Lab Med; 2000 Dec; 20(4):785-815. PubMed ID: 11221515
[TBL] [Abstract][Full Text] [Related]
30. Classification and staging of melanoma.
Gershenwald JE; Buzaid AC; Ross MI
Hematol Oncol Clin North Am; 1998 Aug; 12(4):737-65. PubMed ID: 9759577
[TBL] [Abstract][Full Text] [Related]
31. Prognostic factors in patients with localized primary cutaneous melanoma.
Mervic L
Acta Dermatovenerol Alp Pannonica Adriat; 2012; 21(2):27-31. PubMed ID: 23000937
[TBL] [Abstract][Full Text] [Related]
32. Bioinformatic and Machine Learning Applications in Melanoma Risk Assessment and Prognosis: A Literature Review.
Ma EZ; Hoegler KM; Zhou AE
Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828357
[TBL] [Abstract][Full Text] [Related]
33. Staging Melanoma: What's Old and New.
Ramalingam K; Allamaneni SS
Surg Clin North Am; 2020 Feb; 100(1):29-41. PubMed ID: 31753114
[TBL] [Abstract][Full Text] [Related]
34. Validation of the American Joint Committee on Cancer Eighth Edition Staging of Patients With Metastatic Cutaneous Melanoma Treated With Immune Checkpoint Inhibitors.
Waninger JJ; Ma VT; Journey S; Skvarce J; Chopra Z; Tezel A; Bryant AK; Mayo C; Sun Y; Sankar K; Ramnath N; Lao C; Sussman JB; Fecher L; Alva A; Green MD
JAMA Netw Open; 2021 Mar; 4(3):e210980. PubMed ID: 33687443
[TBL] [Abstract][Full Text] [Related]
35. Final version of 2009 AJCC melanoma staging and classification.
Balch CM; Gershenwald JE; Soong SJ; Thompson JF; Atkins MB; Byrd DR; Buzaid AC; Cochran AJ; Coit DG; Ding S; Eggermont AM; Flaherty KT; Gimotty PA; Kirkwood JM; McMasters KM; Mihm MC; Morton DL; Ross MI; Sober AJ; Sondak VK
J Clin Oncol; 2009 Dec; 27(36):6199-206. PubMed ID: 19917835
[TBL] [Abstract][Full Text] [Related]
36. Using an electronic self-completion tool to identify patients at increased risk of melanoma in Australian primary care.
Habgood E; Walter FM; O'Hare E; McIntosh J; McCormack C; Emery JD
Australas J Dermatol; 2020 Aug; 61(3):231-236. PubMed ID: 32050041
[TBL] [Abstract][Full Text] [Related]
37. Prediction of positron emission tomography/computed tomography (PET/CT) positivity in patients with high-risk primary melanoma.
Danielsen M; Kjaer A; Wu M; Martineau L; Nosrati M; Leong SP; Sagebiel RW; Miller JR; Kashani-Sabet M
Am J Nucl Med Mol Imaging; 2016; 6(5):277-285. PubMed ID: 27766186
[TBL] [Abstract][Full Text] [Related]
38. F-18-fluoro-2-deoxyglucose positron emission tomography (PET) and PET/computed tomography imaging in primary staging of patients with malignant melanoma: a systematic review.
Schröer-Günther MA; Wolff RF; Westwood ME; Scheibler FJ; Schürmann C; Baumert BG; Sauerland S; Kleijnen J
Syst Rev; 2012 Dec; 1():62. PubMed ID: 23237499
[TBL] [Abstract][Full Text] [Related]
39. Circulating cell-free microRNAs in cutaneous melanoma staging and recurrence or survival prognosis.
Polini B; Carpi S; Romanini A; Breschi MC; Nieri P; Podestà A
Pigment Cell Melanoma Res; 2019 Jul; 32(4):486-499. PubMed ID: 30481404
[TBL] [Abstract][Full Text] [Related]
40. Clinical Value of PET/CT in Staging Melanoma and Potential New Radiotracers.
Annunziata S; Laudicella R; Caobelli F; Pizzuto DA; Aimn Working Group Y
Curr Radiopharm; 2020; 13(1):6-13. PubMed ID: 31749438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
